PrabotulinumtoxinA-Xvfs

DRUG4 trials

Sponsors

Evolus, Inc., Lupo Center for Aesthetic and General Dermatology, Kalpna Kay Durairaj, MD, FACS, Boston Medical Center

Conditions

Glabellar Frown LinesNeck Muscle IssueRhytidesSkin AgingSkin Wrinkling

Early Phase 1

Spread of PrabotulinumtoxinA-xvfs Versus OnabotulinumtoxinA in the Treatment of Forehead Rhytides

CompletedNCT05807412

Lupo Center for Aesthetic and General DermatologyRhytides

Start: 2023-05-01End: 2024-02-26Updated: 2024-03-13

Phase 1

Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture

CompletedNCT06604832

Kalpna Kay Durairaj, MD, FACSSkin Aging, Skin Wrinkling

Start: 2024-09-03End: 2025-09-16Updated: 2025-10-21

Phase 2

Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar Lines

CompletedNCT05320393

Evolus, Inc.Glabellar Frown Lines

Start: 2022-03-30End: 2023-05-22Updated: 2024-09-04

Phase 4

BoTox Into the Sternocleidomastoid Muscles (SCM)

RecruitingNCT06903975

Boston Medical CenterNeck Muscle Issue

Start: 2025-05-14End: 2026-03-31Target: 30Updated: 2025-06-05